NXS 1.92% 25.5¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-10

  1. 221 Posts.
    lightbulb Created with Sketch. 121
    When you are growing at 80% compound per annum and adding new customers daily, to expect your quarterly cashflow from sales to equal your quarterly revenue is just silly. I doubt they have many customers who are on a cash only basis. Most of their customers would have negotiated at least 30 days and probably more to pay their accounts. A fair few of their customers are huge hospital groups or medical conglomerates. As a consequence, there will always be a lag between a sale and receipt of cash and in a business growing like the clappers, this is even more pronounced.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $72.92M
Open High Low Value Volume
25.0¢ 25.5¢ 25.0¢ $1.217K 4.856K

Buyers (Bids)

No. Vol. Price($)
1 7 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 92892 3
View Market Depth
Last trade - 10.55am 21/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.